PCV117 COST-UTILITY OF BOSENTAN IN THE FIRST-LINE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN FINLAND-A DISCRETE EVENT SIMULATION MODELLING
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74644-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)74644-1/fulltext
Title :
PCV117 COST-UTILITY OF BOSENTAN IN THE FIRST-LINE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN FINLAND-A DISCRETE EVENT SIMULATION MODELLING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74644-1&doi=10.1016/S1098-3015(10)74644-1
First page :
Section Title :
Open access? :
No
Section Order :
573